Oxford Endovascular

Developer of treatment device for neurovascular disease

placeOxford, England, United Kingdom calendar_todayFounded 2015 groups7 employees language oxfordendovascular.com

Registered entities

Investor mix

13 investors on record; lead investors include Vulpes Investment Management.

Investor typeCountShare
Venture capital323%
Private equity18%
Accelerator & incubator431%
Other / undisclosed538%
Coming soon